Copper histidinate therapy in Menkes' disease: prevention of progressive neurodegeneration.
Sherwood
G
G
Metabolic Diseases Center, Baylor University Medical Center, Dallas, TX.
Sarkar
B
B
Kortsak
A S
AS
D001928:Brain Diseases, Metabolic / Q000188:drug therapy*; D003300:Copper / Q000378:metabolism; D006639:Histidine / Q000138:chemical synthesis / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D007706:Menkes Kinky Hair Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D009410:Nerve Degeneration / Q000187:drug effects*; D009942:Organometallic Compounds / Q000138:chemical synthesis / Q000627:therapeutic use*
D009942:Organometallic Compounds; C045576:copper bis(histidinate); D006639:Histidine; D003300:Copper